Weekly Insider Sells Highlight: ORCL, ALXN, WAT, XRAY

Author's Avatar
Dec 08, 2014

According to GuruFocus Insider Data, the largest insider sells during the past week were: Oracle Corporation (ORCL, Financial), Alexion Pharmaceuticals Inc (ALXN, Financial), Waters Corp (WAT, Financial) and DENTSPLY International Inc (XRAY, Financial).

The overall trend of insiders is illustrated in the chart below:

Oracle Corporation (ORCL, Financial): Chairman of the Board Jeffrey Henley sold 500,000 shares

Chairman of the Board Jeffrey Henley sold 500,000 shares of ORCL stock on 11/28/2014 at the average price of $42.09. Jeffrey Henley owns at least 1,934,516 shares after this. The price of the stock has decreased by 0.38% since.

Oracle Corporation was incorporated in Delaware on September 9, 2005. Oracle Corporation has a market cap of $187.93 billion; its shares were traded at around $41.93 with a P/E ratio of 17.50 and P/S ratio of 4.98. The dividend yield of Oracle Corporation stocks is 1.14%. Oracle Corporation had an annual average earnings growth of 18.00% over the past 10 years. GuruFocus rated Oracle Corporation the business predictability rank of 4.5-star.

Oracle has released its fiscal first quarter 2015 results ended August 31, 2014. Total revenues for the quarter were $8.6 billion, a 3% increase compared to total revenues of $8.37 billion reported in the year ago period. Net income was flat at $2.18 billion, and diluted EPS were $0.48.

Director Michael J Boskin sold 50,000 shares of ORCL stock on 11/28/2014 at the average price of $42.

Alexion Pharmaceuticals Inc (ALXN, Financial): EVP & CFO Vikas Sinha sold 75,000 shares

EVP & CFO Vikas Sinha sold 75,000 shares of ALXN stock on 12/03/2014 at the average price of $198.96. Vikas Sinha owns at least 162,770 shares after this. The price of the stock has decreased by 0.18% since.

Alexion Pharmaceuticals Inc is a Delaware-based company, incorporated in 1992. Alexion Pharmaceuticals Inc has a market cap of $38.65 billion; its shares were traded at around $198.61 with a P/E ratio of 82.60 and P/S ratio of 19.30. Alexion Pharmaceuticals Inc had an annual average earnings growth of 52.40% over the past 5 years.

Alexion reported third quarter net product sales of $555.1 million, compared to $400.4 million a year ago. Third quarter GAAP EPS increased 87% to $0.88, and non-GAAP EPS increased 53% to $1.27.

CEO Leonard Bell sold 5,210 shares of ALXN stock on 11/20/2014 at the average price of $191.96.

Waters Corp (WAT, Financial): EVP and President, Waters Div Arthur G Caputo sold 100,000 shares

EVP and President, Waters Div Arthur G Caputo sold 100,000 shares of WAT stock on 12/04/2014 at the average price of $116.64. Arthur G Caputo owns at least 90,412 shares after this. The price of the stock has decreased by 1.02% since.

Waters Corp incorporated as a Delaware corporation in 1991, is an analytical instrument manufacturer. The company mainly designs, manufactures, sells and services, through its Waters Division, high performance liquid chromatography, ultra performance liquid chromatography and mass spectrometry instrument systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. Waters Corp has a market cap of $9.65 billion; its shares were traded at around $115.45 with a P/E ratio of 23.40 and P/S ratio of 5.00. Waters Corp had an annual average earnings growth of 11.40% over the past 10 years. GuruFocus rated Waters Corp the business predictability rank of 4-star.

Waters Corp reported third quarter 2014 earnings of $113.5 million and had profit of $1.34 per share.

CHAIRMAN, PRESIDENT & CEO Douglas A Berthiaume sold 102,423 shares of WAT stock on 12/04/2014 at the average price of 117. Douglas A Berthiaume owns at least 2,239,036 shares after this. The price of the stock has decreased by 1.32% since.

DENTSPLY International Inc (XRAY, Financial): Chairman & C.E.O. Bret W Wise sold 197,400 shares

Chairman & C.E.O. Bret W Wise sold 197,400 shares of XRAY stock on 12/01/2014 at the average price of $54.08. Bret W Wise owns at least 266,764 shares after this. The price of the stock has increased by 3.61% since.

DENTSPLY International, Inc. was incorporated in 1899 in Delaware. Dentsply International Inc has a market cap of $7.78 billion; its shares were traded at around $56.03 with a P/E ratio of 26.00 and P/S ratio of 2.74. The dividend yield of Dentsply International Inc stocks is 0.47%. Dentsply International Inc had an annual average earnings growth of 10.30% over the past 10 years. GuruFocus rated Dentsply International Inc the business predictability rank of 3.5-star.

For its third quarter of 2014, Dentsply reported net sales of $708 million. Net income was $75 million, or $0.52 per share, compared to $80 million, or $0.55 per share for the prior year quarter. On an adjusted basis, diluted EPS increased 9% to $0.62.

Senior VP Albert Sterkenburg sold 23,200 shares of XRAY stock on 12/04/2014 at the average price of $55.62.

For the complete list of stocks that bought/sold by their company executives, go to: Insider Buys.